Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT02023905
Status:
TERMINATED
Last Update Posted:
2022-12-29
First Post:
2013-12-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Sponsor:
University of California, San Francisco
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Novartis-CRAD001CUS225T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |